RICHMOND, BC, Canada--Xillix Technologies Corp. has closed the
North American multicenter clinical trial of its LIFE (lung imaging
fluorescence endoscope)-Lung Imaging System that began in April,
The system uses tissue autofluo-rescence to enhance the physician's
ability to locate suspicious lung tissue for biopsy. By using
blue rather than conventional white light, the system can pick
up subtle differences between precancerous or cancerous tissue
and normal tissue, the company said.
Preliminary data showed a relative improvement of 161% in the
ability to identify suspicious tissue for moderate to severe dysplasia
or worse when the LIFE System was used as an adjunct to white
light bronchoscopy versus white light bronchoscopy alone.